Patents by Inventor Ian R. Duffy

Ian R. Duffy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • EGFR-CMET-TARGETED COMPOUNDS AND USES THEREOF
    Publication number: 20250121104
    Abstract: Compounds, e.g., radioimmunoconjugates, including a chelating moiety or a metal complex thereof, a linker, and an antibody or antigen-binding fragment thereof targeting both EGFR and cMET. Pharmaceutical compositions of such compounds and methods of treatment for conditions, e.g., cancer, using such compounds or pharmaceutical compositions.
    Type: Application
    Filed: December 20, 2022
    Publication date: April 17, 2025
    Inventors: Sadaf AGHEVLIAN, Natalie GRINSHTEIN, Ian R. DUFFY, Thomas I. KOSTELINK, Andrew Grier BUCHANAN, Yariv MAZOR, Srinath KASTURIRANGAN, Qun DU, Chunning YANG, Frank Irvine COMER
  • EGFRVIII-TARGETED COMPOUNDS AND USES THEREOF
    Publication number: 20240408249
    Abstract: Compounds, e.g., radioimmunoconjuguates including a chelating moiety or a metal complex thereof, a linker, and an EGFRVIII targeting moiety. Pharmaceutical compositions of such compounds and methods of treatment for conditions. e.g., cancer, using such compounds or pharmaceutical compositions.
    Type: Application
    Filed: September 29, 2022
    Publication date: December 12, 2024
    Inventors: Natalie Grinshtein, Julie Metcalf, Ian R. Duffy, William Leslie Turnbull, Anne Marcil, Maria Jaramillo, Traian Sulea, Maria Moreno, Cunle Wu
  • Radiation curable solid ink compositions suitable for transfuse printing applications
    Patent number: 8449095
    Abstract: This disclosure is generally directed to curable solid inks, such as radiation-curable solid inks, and their use in forming images, such as through transfuse printing. More specifically, this disclosure is directed to radiation-curable solid inks, such as ultraviolet-light-curable phase-change inks, that comprise curable and non-curable waxes.
    Type: Grant
    Filed: July 13, 2010
    Date of Patent: May 28, 2013
    Assignee: Xerox Corporation
    Inventors: Marcel P. Breton, Michelle N. Chretien, Christopher A. Wagner, Ian R. Duffy, Peter G. Odell
  • Curable solid ink compositions
    Patent number: 8236870
    Abstract: A curable solid ink composition including a curable component, a non-curable component including an ethoxylated octylphenol derivative, a photoinitiator, and a colorant. The curable solid ink composition has a viscosity in the range of less than 10 cPs at 90° C., a shrinkage value of less than 3%, and a superior curing rate compared to existing curable solid ink compositions. The ethoxylated octylphenol derivatives may be prepared by reacting an ethoxylated octylphenol, a linear alcohol, and diisocyanates or polyisocyanates.
    Type: Grant
    Filed: February 11, 2010
    Date of Patent: August 7, 2012
    Assignee: Xerox Corporation
    Inventors: Marcel P. Breton, Michelle N. Chretien, Jeffrey H. Banning, Stephan V. Drappel, Ian R. Duffy, Christopher A. Wagner
  • RADIATION CURABLE SOLID INK COMPOSITIONS SUITABLE FOR TRANSFUSE PRINTING APPLICATIONS
    Publication number: 20120013690
    Abstract: This disclosure is generally directed to curable solid inks, such as radiation-curable solid inks, and their use in forming images, such as through transfuse printing. More specifically, this disclosure is directed to radiation-curable solid inks, such as ultraviolet-light-curable phase-change inks, that comprise curable and non-curable waxes.
    Type: Application
    Filed: July 13, 2010
    Publication date: January 19, 2012
    Applicant: XEROX CORPORATION
    Inventors: Marcel P. BRETON, Michelle N. Chrétien, Christopher A. Wagner, Ian R. Duffy, Peter G. Odell
  • CURABLE SOLID INK COMPOSITIONS
    Publication number: 20110196057
    Abstract: A curable solid ink composition including a curable component, a non-curable component including an ethoxylated octylphenol derivative, a photoinitiator, and a colorant. The curable solid ink composition has a viscosity in the range of less than 10 cPs at 90° C., a shrinkage value of less than 3%, and a superior curing rate compared to existing curable solid ink compositions. The ethoxylated octylphenol derivatives may be prepared by reacting an ethoxylated octylphenol, a linear alcohol, and diisocyanates or polyisocyanates.
    Type: Application
    Filed: February 11, 2010
    Publication date: August 11, 2011
    Applicant: XEROX CORPORATION
    Inventors: Marcel P. BRETON, Michelle N. CHRÉTIEN, Jeffrey H. BANNING, Stephan V. DRAPPEL, Ian R. DUFFY, Christopher A. WAGNER